Rajkumar Venkatramani, MD, MS, MBA

Dr. Rajkumar Venkatramani is the section chief of oncology and the director of clinical business operations for Texas Children's Cancer and Hematology Center. He is a professor of pediatrics at Baylor College of Medicine and, is a board-certified pediatric hematologist-oncologist who is internationally recognized for his expertise in the care of children with pediatric solid tumors.

Venkatramani completed his pediatric training at Kings College in London and obtained membership in the Royal College of Pediatrics and Child Health. He completed another pediatric residency at University of Illinois College of Medicine and a fellowship in pediatric hematology oncology at Children’s Hospital Los Angeles. Venkatramani served on the faculty at University of Southern California for three years prior to joining the faculty at Baylor College of Medicine/Texas Children’s Cancer Center in 2014.

At Texas Children’s, Venkatramani has been instrumental in developing a rare tumors program and thyroid cancer program. He has established a national registry for children with rare tumors that will provide important data to physician scientists as they work to find a cure for these often times difficult to treat cancers. As the director of the Rare Tumors Program at Texas Children’s Cancer and Hematology Center, he is involved in management of children with rare cancers, including: melanoma, thyroid tumors, adrenocortical carcinoma, nasopharyngeal carcinoma, neuroendocrine tumors, pleuropulmonary blastoma and salivary gland tumors.

Venkatramani is the scientific chair of Children’s Oncology Group (COG) soft tissue sarcoma committee. In this role he is responsible for developing clinical trials fro children with soft tissue sarcoma in North America. Venkatramani is also a member of the COG Renal Tumor Committee, where he is vice chair of a national clinical trial for children with a type of recurrent or relapsed kidney tumor known as Wilms tumor.

Venkatramani has published more than 100 scientific papers in peer-reviewed journals and has been a recipient of numerous awards, including: The Walter Laug Distinguished Teacher Award for Outstanding Teaching and the Guidance and Inspiration and Outstanding Resident Teacher Award. In 2017, he was appointed to the editorial board of Pediatric Blood and Cancer, the premier publication that focuses on laboratory and clinical investigations for children and adolescents with cancer or blood disorders.

Councils and Committees

Member, Renal Tumor Committee, Children’s Oncology Group, 2013- present
Member, Rare Tumors Committee, Children’s Oncology Group, 2015-present
Chair, Soft Tissue Sarcoma Committee, Children’s Oncology Group, 2020-present